MSF urges US and key donors to help Global Fund meet targets
Global efforts to fight three of the world’s most harmful and widespread infectious diseases—AIDS, tuberculosis and malaria—are now under threat due to dramatic cuts in global health financing, warns Doctors Without Borders (MSF).
In January, the United States—previously the largest funder of global health programs—announced a suspension and review of all international aid. Since then, nearly $3 billion of the $6 billion USD it had pledged to the Global Fund to Fight AIDS, Tuberculosis and Malaria for 2023 to 2025 remains unfulfilled. Key donors, including the US and, have yet to announce pledges for the Global Fund’s next three-year funding cycle, due in November.
“It would be a mortal blow should the Global Fund not meet its replenishment targets at this critical juncture in the response to HIV, TB and malaria. Our data has shown worrying trends of regression in the past 6 months. History will judge us harshly if we stay silent!” Anele Yawa, General Secretary, Treatment Action Campaign (TAC), South Africa
The Global Fund has long played a fundamental role in supporting fragile health systems across Africa, Asia, Latin America and beyond. Its grants help purchase medications and diagnostic tests, pay health workers and sustain disease prevention efforts. Without substantial pledges in the coming weeks and months, decades-long progress in reducing illness and death could be reversed.
MSF, which provides medical care to tens of thousands of patients with HIV or TB and more than 3 million people with malaria each year, is deeply concerned about the impact of weakening support for the Global Fund. While MSF’s work is not financed by the Fund, hundreds of community-based health organisations that rely on its support are now scaling back plans amid financial uncertainty and looming cuts.
“The consequences are already visible,” said Antonio Flores, Senior HIV/TB Advisor, MSF. “In Honduras, abrupt cuts by PEPFAR halted HIV prevention and care programs. Patients lost access to pre-exposure prophylaxis (PrEP) overnight, and health workers lost their jobs. We’re now seeing patients return with advanced opportunistic infections.”
The reality of infectious diseases is that when left unchecked, they worsen and spread. Cutting funding undermines years of hard-won progress, while sustaining successful approaches and supporting promising innovations can save lives.
Despite medical advances, HIV still causes an estimated 1.3 million new infections and more than 600,000 deaths annually. Community-based organisations supported by the
Global Fund have proven highly effective in improving prevention and treatment outcomes. Their progress must not be reversed.
New injectable PrEP offers promising protection for people at high risk of HIV, yet national scale-up efforts in Malawi have stalled due to reduced US funding. Sex workers in the country face HIV prevalence rates nearing 60 percent.
Tuberculosis causes an estimated 1.5 million deaths per year. Thanks to efforts by the Global Fund and the UN High-Level Meeting on TB, fewer cases go undetected. But in Sudan, MSF has witnessed TB testing equipment sitting unused due to lack of trained staff. In Belarus, research on drug-resistant TB supported by MSF and the Global Fund was recently halted due to unfulfilled funding.
Malaria remains the leading cause of death among children under five in endemic countries. MSF teams in the Central African Republic, South Sudan and the Democratic Republic of Congo report frequent shortages of diagnostic tests and medications, and understaffed facilities with deadly consequences for young patients.
“Imagine hearing your unique child’s voice for the last time because of a preventable disease. If the 8th replenishment does not go ahead, it would jeopardize decades of progress, leading to a resurgence of malaria cases and unnecessary loss of lives.” commented Joseph Wato, President COFIS-CSU Cameroon (CSOs Coalition for Health Financing and Universal Health Coverage in Cameroon.
The notion that domestic resource mobilization can replace global health funding is not viable in many of the places MSF works. As highlighted in MSF’s recent report, Deadly Gaps, the cost burden increasingly falls on patients who cannot afford care.
“Entire programs have shut down: As a result, patients are being lost to follow-up, treatment adherence is weakening, and anecdotal evidence points to rising unexplained deaths, possibly linked to psychosocial breakdown, relapse, or food insecurity.” added the Country Director of Youth Alive Liberia, reinforcing the urgent need for sustained international support.
MSF urges key donor countries to maintain its critical support to the Global Fund on behalf of heavily affected communities worldwide. The fight against HIV, tuberculosis and malaria is a global, generational challenge—and it is far from over.
A radiology technician places the patient for an x-ray to diagnose a potential pulmonary tuberculosis at the general referral hospital of Mweso, North-Kivu, supported by MSF teams since 2005 in partnership with the Ministry of Health. Location: DRC | Date: 17/08/2023 | Photographer : Laora Vigourt
IRS team in Angumu, Ituri Province is preparing for the pulverisation of Gokwa village. IRS is one of the pillar to prevent malaria. Location: DRC | Date: 13/01/2025 | Photographer: Fanny Hostettler
Article document.docx
DOCX 17 KB
Msizi Keca
About Doctors Without Borders (MSF)
Doctors Without Borders (MSF) is a global network of principled medical and other professionals who specialise in medical humanitarian work, driven by our common humanity and guided by medical ethics. We strive to bring emergency medical care to people caught in conflicts, crises, and disasters in more than 70 countries worldwide.
In South Africa, we currently run a non-communicable diseases (NCDs) project in Butterworth, Eastern Cape province, where we support the Department of Health (DoH) in improving care for patients with diabetes and hypertension. The project focuses on improving screening, diagnosis, management, and prevention of NCDs through advocacy, research, health promotion, training, and mentorship of Community Healthcare Workers.
MSF is also recognised as one of the pioneers in providing antiretroviral treatment (ART) in the public sector. It started the first HIV programme in South Africa in 1999. The organisation's earlier interventions in the country have primarily been on developing new testing and treatment strategies for HIV/AIDS and Tuberculosis (TB) in Eshowe (Kwa-Zulu Natal) and Khayelitsha (Western Cape). The Eshowe project was handed over to DoH in 2023 after 12 years of operations. The Khayelitsha project was closed in 2020 after 22 years of activities and campaigning for improved HIV and TB treatment.
Other projects we have been involved in include our Migrant Project in the country's capital, Tshwane, which was handed over to authorities and a local Community-Based Organisation after building the capacity to work with undocumented populations. We also previously offered free, high-quality, and confidential medical care to survivors of sexual and gender-based violence in Rustenburg, North West province.
To learn more about our work in South Africa, please visit this page on our website (www.msf.org.za). To support MSF’s work:
- SMS “JOIN” to 42110 to donate R30 Once-off
- Visit https://www.msf.org.za/donate